Navigation Links
RainEarth Obtains Patent Approvals for Its Core Technology
Date:6/26/2009

BEIJING, June 26 /PRNewswire-Asia/ -- RainEarth Inc. (OTC Bulletin Board: RNER; "the Company"), announced that its contractual partner in China, Beijing RainEarth Technology Co. Ltd., ("China RainEarth"), has obtained patent approvals for its core technology, which consists of products that aid in manufacturing blood dialysis.

China RainEarth applied for and was approved for patents for its core technology with the State Intellectual Property Office of P.R.C. (SIPO). These patents include:

    -- Mass production method for hollow fiber membranes
    -- Quick cleaning equipment for hollow fiber membranes
    -- Quick drying equipment for hollow fiber membranes
    -- Device for adjusting dry spinning range in hollow fiber membrane
       dry-wet spinning and control condensation bath process concentration
       control
    -- Manufacturing technique for blended PES hollow fiber dialysis membrane
    -- Synthetic hollow fiber membrane continuous spinning device
    -- Hollow fiber membrane porous spinneret component
    -- Hollow fiber tube-in-orifice spinneret

"These patents will not only help to ensure that competitive prices are maintained in the production of these materials, but also that the highest level of quality possible is provided. We have also put RainEarth in a strong market position by applying for these patents before our competitors. With these technologies and sufficient funds, we can increase our production from 150,000 blood dialysis to between 1.5-3.2 million. This will generate revenue in the area of $12-32 million (USD)," said Mr. Zhu, CEO of the Company.

About the Company

RainEarth Inc. (formerly Gold Rock Resources Inc., the "Company") was incorporated in the State of Nevada on March 14, 2006. The Company is a developing stage company that initially engages in the search for mineral deposits or reserves.

On March 25, 2009, the Company and China RainEarth, a company organized and existing under the laws of the People's Republic of China, entered into a Business Cooperation Agreement (the "Agreement") for a term of twenty years. The purpose of the Agreement is to jointly conduct Hollow Fiber Membrane Materials' application and manufacturing business in China (the "Business"). The first product that utilizes this technology is blood dialyzer.

The Company will provide Advice and assistance relating to development of marketing and consultancy services, particularly as related to the Business. China RainEarth will give 60% of its revenue after deduction of direct operating costs, expenses and taxes to the Company in consideration of the Company's services.

Forward-looking statements

This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts included in this press release are forward-looking statements. Forward-looking statements involve risks and uncertainties including, but not limited to, economic and political factors; developments of the Chinese and North American markets and changes in regulatory matters; our business strategies and future plans of operations; the market acceptance and amount of sales of our products and services; our historical losses; the competitive environment within the industries in which we compete; and our ability to raise additional capital, currently needed for expansion. The Company cautions that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements due to several important factors.

    For more information, please contact:

     RainEarth Inc.
     Public Relationship Department
     Tel:   +852-3005-7220
     Email: Investor@rainearth.net

'/>"/>
SOURCE RainEarth Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Gold Rock Changed Name to RainEarth Inc. and Launches New English Web Site
2. RainEarth Applies for Patent for Second Generation Blood Dialysis Equipment
3. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
4. Patient Lift Manufacturer, Medcare Products, Obtains Women-Owned Certification
5. Aspreva obtains shareholder approval for acquisition by Galenica
6. VIE Healthcare Expands Its Operations in the Midwest, and Obtains First Local Client
7. DRAXIS Obtains Interim Order for Proposed Arrangement
8. DRAXIS Obtains Final Order for Proposed Arrangement
9. China Medicine Corporation Obtains Australian Patent for rADTZ
10. William F. McMurry - Lead Class Counsel Obtains $16.4 Million Settlement for Elderly Clients
11. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... and its sugar-free alternative VW+ 002. The drinks have been produced in collaboration ... conditions to perform during your workout. , After a successful launch in Sweden ...
(Date:1/20/2017)... ... 2017 , ... “The Angel”: a heartwarming and earnest tale of faith ... his children. “The Angel” is the creation of published author, Marjorie Lund-Fontaine, a former ... impassioned writer. , When asked of her new book, Marjorie says, “‘The Angel’ was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated ... CyberKnife® and TomoTherapy® Systems continue to set the bar ... the highest composite overall user satisfaction rating among radiation ... Q4 2016 MD Buyline Market Intelligence Briefing™. The most ... highest composite ratings among industry peers for 11 of ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
Breaking Medicine Technology: